These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 30876393
1. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan. Chen ST, Huang ST, Shau WY, Lai CL, Li JZ, Fung S, Tse VC, Lai MS. BMC Cardiovasc Disord; 2019 Mar 15; 19(1):62. PubMed ID: 30876393 [Abstract] [Full Text] [Related]
2. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study. Anderson JL, Knowlton KU, May HT, Bair TL, Armstrong SO, Lappé DL, Muhlestein JB. J Clin Lipidol; 2018 Mar 15; 12(4):1008-1018.e1. PubMed ID: 29703626 [Abstract] [Full Text] [Related]
5. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Corrao G, Conti V, Merlino L, Catapano AL, Mancia G. Clin Ther; 2010 Feb 15; 32(2):300-10. PubMed ID: 20206788 [Abstract] [Full Text] [Related]
14. High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study. May HT, Knowlton KU, Anderson JL, Lappé DL, Bair TL, Muhlestein JB. Eur Heart J Qual Care Clin Outcomes; 2022 May 05; 8(3):352-360. PubMed ID: 33787865 [Abstract] [Full Text] [Related]
16. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk. Lin I, Sung J, Sanchez RJ, Mallya UG, Friedman M, Panaccio M, Koren A, Neumann P, Menzin J. J Manag Care Spec Pharm; 2016 Jun 05; 22(6):685-98. PubMed ID: 27231796 [Abstract] [Full Text] [Related]
17. Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis. Yew PY, Loth M, Adam TJ, Wolfson J, Liang Y, Tonellato PJ, Chi CL. BMC Cardiovasc Disord; 2024 May 10; 24(1):245. PubMed ID: 38730371 [Abstract] [Full Text] [Related]
18. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus. Malmborg M, Schmiegelow MDS, Gerds T, Schou M, Kistorp C, Torp-Pedersen C, Gislason G. J Am Heart Assoc; 2021 Jul 06; 10(13):e020395. PubMed ID: 34151606 [Abstract] [Full Text] [Related]
19. Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis. Toth PP, Granowitz C, Hull M, Anderson A, Philip S. Lipids Health Dis; 2019 Sep 16; 18(1):175. PubMed ID: 31526399 [Abstract] [Full Text] [Related]
20. Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan. Chen WJ, Wen YC, Fox KM, Shen LJ, Lin LY, Qian Y, Zhao Z, Rane PP, Hsiao FY. J Eval Clin Pract; 2020 Aug 16; 26(4):1171-1180. PubMed ID: 31646715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]